{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:03:23Z","timestamp":1756573403554},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,13]]},"DOI":"10.7759\/cureus.62324","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:03:33Z","timestamp":1718298213000},"source":"Crossref","is-referenced-by-count":3,"title":["Emerging Technologies in Endocrine Drug Delivery: Innovations for Improved Patient Care"],"prefix":"10.7759","author":[{"given":"Mahvish","family":"Renzu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Hubers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoriya","family":"Gibatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/23626.9732","article-title":"Inhaled insulin - current direction of insulin research","volume":"11","author":"Mohanty RR","year":"2017","unstructured":"Mohanty RR, Das S. Inhaled insulin - current direction of insulin research. J Clin Diagn Res. 2017, 11:OE01-2. 10.7860\/JCDR\/2017\/23626.9732","journal-title":"J Clin Diagn Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.19.1.13","article-title":"Inhaled insulin: an overview","volume":"19","author":"White J","year":"2001","unstructured":"White J, Campbell RK. Inhaled insulin: an overview. Clin Diabet. 2001, 19:13-6. 10.2337\/diaclin.19.1.13","journal-title":"Clin Diabet"},{"key":"ref3","unstructured":"Inhale-3. Afrezza\u00ae combined with insulin degludec versus usual care in adults with type 1 diabetes. (2023). Accessed: February 13, 2024: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05904743."},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57111209","article-title":"Peptide-based drug delivery systems","volume":"57","author":"Berillo D","year":"2021","unstructured":"Berillo D, Yeskendir A, Zharkinbekov Z, Raziyeva K, Saparov A. Peptide-based drug delivery systems. Medicina. 2021, 57:1209.","journal-title":"Medicina"},{"key":"ref5","article-title":"Novel peptide-based tissue-delivery technology","author":"Park YJ","year":"2023","unstructured":"Park YJ. Novel peptide-based tissue-delivery technology. Biopharma Dealmakers. 2023, B36.","journal-title":"Biopharma Dealmakers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00938-1","article-title":"A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects","volume":"12","author":"Dhalla AK","year":"2022","unstructured":"Dhalla AK, Al-Shamsie Z, Beraki S, et al.. A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects. Drug Deliv Transl Res. 2022, 12:294-305. 10.1007\/s13346-021-00938-1","journal-title":"Drug Deliv Transl Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad114.531","article-title":"Sat235 an orally administered robotic pill (RP) reliably and safely delivers the human parathyroid hormone analog hpth(1-34) (teriparatide) with high bioavailability in healthy human volunteers: a phase 1 study","volume":"7","author":"Myers JT","year":"2023","unstructured":"Myers JT, Dasari A, Battiwala A, et al.. Sat235 an orally administered robotic pill (RP) reliably and safely delivers the human parathyroid hormone analog hpth(1-34) (teriparatide) with high bioavailability in healthy human volunteers: a phase 1 study. J Endocr Soc. 2023, 7:bvad114.531. 10.1210\/jendso\/bvad114.531","journal-title":"J Endocr Soc"},{"key":"ref8","unstructured":"Robotic pill safely delivers injectable osteoporosis drug. (2023). Accessed. June 20, 2023: https:\/\/www.openaccessgovernment.org\/robotic-pill-safely-delivers-injectable-osteoporosis-drug\/161379\/."},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-2410","article-title":"Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes","volume":"36","author":"Henry RR","year":"2013","unstructured":"Henry RR, Rosenstock J, Logan DK, Alessi TR, Luskey K, Baron MA. Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes. Diabetes Care. 2013, 36:2559-65.","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2013.12.009","article-title":"Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes","volume":"28","author":"Henry RR","year":"2014","unstructured":"Henry RR, Rosenstock J, Logan D, Alessi T, Luskey K, Baron MA. Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes. J Diabetes Compl. 2014, 28:393-8. 10.1016\/j.jdiacomp.2013.12.009","journal-title":"J Diabetes Compl"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0177","article-title":"Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence","volume":"45","author":"Moon SJ","year":"2021","unstructured":"Moon SJ, Jung I, Park CY. Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence. Diabetes Metab J. 2021, 45:813-39. 10.4093\/dmj.2021.0177","journal-title":"Diabetes Metab J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/s17030532","article-title":"Use of wearable sensors and biometric variables in an artificial pancreas system","volume":"17","author":"Turksoy K","year":"2017","unstructured":"Turksoy K, Monforti C, Park M, Griffith G, Quinn L, Cinar A. Use of wearable sensors and biometric variables in an artificial pancreas system. Sensors (Basel). 2017, 17:532. 10.3390\/s17030532","journal-title":"Sensors (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820983863","article-title":"Digital diabetes management: a literature review of smart insulin pens","volume":"16","author":"Heinemann L","year":"2022","unstructured":"Heinemann L, Schnell O, Gehr B, Schloot NC, G\u00f6rgens SW, G\u00f6rgen C. Digital diabetes management: a literature review of smart insulin pens. J Diabetes Sci Technol. 2022, 16:587-95. 10.1177\/1932296820983863","journal-title":"J Diabetes Sci Technol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201001091","article-title":"Dissolving microneedle patch for transdermal delivery of human growth hormone","volume":"7","author":"Lee JW","year":"2011","unstructured":"Lee JW, Choi SO, Felner EI, Prausnitz MR. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small. 2011, 7:531-9. 10.1002\/smll.201001091","journal-title":"Small"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00944-3","article-title":"Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention","volume":"12","author":"GhavamiNejad A","year":"2022","unstructured":"GhavamiNejad A, Lu B, Samarikhalaj M, et al.. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. Drug Deliv Transl Res. 2022, 12:792-804. 10.1007\/s13346-021-00944-3","journal-title":"Drug Deliv Transl Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040215","article-title":"Self-dissolving microneedle arrays for transdermal absorption enhancement of human parathyroid hormone (1-34)","volume":"10","author":"Naito C","year":"2018","unstructured":"Naito C, Katsumi H, Suzuki T, Quan YS, Kamiyama F, Sakane T, Yamamoto A. Self-dissolving microneedle arrays for transdermal absorption enhancement of human parathyroid hormone (1-34). Pharmaceutics. 2018, 10:215. 10.3390\/pharmaceutics10040215","journal-title":"Pharmaceutics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24030603","article-title":"Hydrogels and their applications in targeted drug delivery","volume":"24","author":"Narayanaswamy R","year":"2019","unstructured":"Narayanaswamy R, Torchilin VP. Hydrogels and their applications in targeted drug delivery. Molecules. 2019, 24:603. 10.3390\/molecules24030603","journal-title":"Molecules"},{"key":"ref18","unstructured":"New drug delivery system could reduce daily diabetes shots to just three a year. (2023). Accessed.  November 21, 2023: https:\/\/news.stanford.edu\/stories\/2023\/11\/drug-delivery-system-reduce-daily-diabetes-shots-just-three-year."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261395-emerging-technologies-in-endocrine-drug-delivery-innovations-for-improved-patient-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:03:39Z","timestamp":1718298219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261395-emerging-technologies-in-endocrine-drug-delivery-innovations-for-improved-patient-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.62324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}